Advertisement for orthosearch.org.uk
Results 1 - 2 of 2
Results per page:
Applied filters
Content I can access

Include Proceedings
Dates
Year From

Year To
Orthopaedic Proceedings
Vol. 98-B, Issue SUPP_23 | Pages 2 - 2
1 Dec 2016
Brandsaeter B Jenssen KK Høvik Ø Amlie E Aamodt A
Full Access

Aim

Early prosthetic joint infection (PJI) is a feared complication of hip arthroplasty. Debridement, antibiotics and implant retention (DAIR) is attempted to avoid removal of the implant. The aim of this retrospective cohort study was to evaluate the success rate of DAIR in early PJI.

Method

All patients who were diagnosed with early PJI and treated with DAIR at our center from 2003 to 2013 were included in the study. During the time period, 5176 primary hip arthroplasties and 555 revision hip arthroplasties were performed. Early PJI was diagnosed in 54 patients (43 primary and 11 revisions). Median follow-up was 5.6 years (range 2.0–12.1). Standard postoperative antibiotic treatment at our centre is vancomycin and rifampicin.


Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXXVII | Pages 562 - 562
1 Sep 2012
Petursson G Hovik O Bjerre S Amlie E Furnes O Röhrl S
Full Access

Background

Tranexamic acid (TA) in total knee replacement surgery (TKR) has shown marked reduction in bleeding and blood transfusion. There are little data on TA in revision TKR. From February 2008 all patients having primary or revision TKR received TA 10mg/kg × 2. We whished to evaluate the effect and possible complications of TA.

Patients and Methods

49 patients had revision TKR from January to August 2010. 21 patients (group I) operated before the regular use of TA were compared to 28 patients (group II) receiving TA. The groups were compared according to bleeding, blood transfusion, postoperative complication and type of revision. Revision TKR was compared to 157 primary TKR (94 operated without TA (group III) and 63 who received TA (group IV).